Watch Ticker

Bicycle Therapeutics plc American Depositary Shares

Go to Bicycle Therapeutics plc American Depositary Shares Website

$7.86

0.00 (0.00%)

Live

Previous Close

$7.86

Day Range

$0 - $0

Previous Day Range

$7.77 - $8.19

Market Cap

$557.5 million USD

Day Vol.

Previous Day Vol.

271703

Currency

USD

Primary Exchange

Nasdaq

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The advanced urothelial carcinoma market is witnessing significant growth, driven by an aging population and the rising prevalence of metastatic cases. Advances in immunotherapy and targeted treatments are transforming the treatment landscape, with over 20 key companies developing new therapies.

Related tickers: BCYC, BMY, CELGr, TYRA, BGNE, ONC.

Read Full Article

Zacks Equity Research - Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year?

Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Twist Bioscience (TWST) have performed compared to their sector so far this year.

Related tickers: BCYC, TWST.

Read Full Article

Trending Tickers

Please sign in to view